Voclosporin Is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
European Renal Association Congress 2022: Early Reductions in Proteinuria with Voclosporin Treatment across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV and AURORA 1 Trials
European Renal Association Congress 2022: Voclosporin for Lupus Nephritis: Results of the Two-year AURORA 2 Continuation Study
EULAR 2021: Real-world Economic Implications of Achieving Low Disease Activity in Lupus Nephritis - Presented by Dr Paola Mina-Osorio
EULAR 2021: Voclosporin for Lupus Nephritis: Interim Analysis of the AURORA 2 Extension Study - Presented by Dr Amit Saxena
Voclosporin Increases Renal Response at Commonly Used UPCR Thresholds in Patients with Lupus Nephritis
European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) 2020 Virtual Congress
